These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12499217)

  • 1. Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains.
    Loeffler JM; Fischetti VA
    Antimicrob Agents Chemother; 2003 Jan; 47(1):375-7. PubMed ID: 12499217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
    J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance.
    Djurkovic S; Loeffler JM; Fischetti VA
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1225-8. PubMed ID: 15728935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.
    Loeffler JM; Djurkovic S; Fischetti VA
    Infect Immun; 2003 Nov; 71(11):6199-204. PubMed ID: 14573637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.
    Loeffler JM; Nelson D; Fischetti VA
    Science; 2001 Dec; 294(5549):2170-2. PubMed ID: 11739958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
    Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
    J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus.
    Letrado P; Corsini B; Díez-Martínez R; Bustamante N; Yuste JE; García P
    Future Microbiol; 2018 Sep; 13(11):1215-1223. PubMed ID: 30238774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module.
    Díez-Martínez R; de Paz HD; Bustamante N; García E; Menéndez M; García P
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5355-65. PubMed ID: 23959317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of serotypes and antimicrobial resistance of invasive strains of Streptococcus pneumoniae].
    Mantese OC; Paula A; Moraes AB; Moreira TA; Guerra ML; Brandileone MC
    J Pediatr (Rio J); 2003; 79(6):537-42. PubMed ID: 14685452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.
    Vouillamoz J; Entenza JM; Giddey M; Fischetti VA; Moreillon P; Resch G
    Int J Antimicrob Agents; 2013 Nov; 42(5):416-21. PubMed ID: 23992647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland.
    Wüst J; Huf E; Kayser FH
    J Clin Microbiol; 1995 Dec; 33(12):3159-63. PubMed ID: 8586693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada.
    Louie M; Louie L; Papia G; Talbot J; Lovgren M; Simor AE
    J Infect Dis; 1999 Apr; 179(4):892-900. PubMed ID: 10068584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy.
    Marchese A; Tonoli E; Balistreri G; Debbia E; Schito GC
    Microb Drug Resist; 2000; 6(2):163-70. PubMed ID: 10990272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in Kayseri, Turkey.
    Esel D; Sümerkan B; Kocagöz S
    Clin Microbiol Infect; 2001 Oct; 7(10):548-52. PubMed ID: 11683795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of invasive infections in children caused by highly penicillin-resistant Streptococcus pneumoniae compared with infections caused by penicillin-susceptible strains.
    Gómez-Barreto D; Calderón-Jaimes E; Rodríguez RS; de los Monteros LE
    Arch Med Res; 2000; 31(6):592-8. PubMed ID: 11257327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in a university hospital, Ankara, Turkey.
    Pinar A; Köseoğlu O; Yenişehirli G; Sener B
    Clin Microbiol Infect; 2004 Aug; 10(8):718-23. PubMed ID: 15301674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].
    Reinert RR; Lütticken R; Kaufhold A
    Med Klin (Munich); 1993 Jun; 88(6):357-61. PubMed ID: 8336662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A;
    J Antimicrob Chemother; 2004 Jul; 54(1):247-50. PubMed ID: 15140858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus.
    Johnson AP; Warner M; Speller DC
    J Antimicrob Chemother; 1998 Nov; 42(5):643-6. PubMed ID: 9848449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.